Literature DB >> 31347925

Advances on Cell Autophagy and Its Potential Regulatory Factors in Renal Ischemia-Reperfusion Injury.

Jing Hou1,2,3, Mingyue Rao1,2,4, Wenlu Zheng1,2,5, Junming Fan6,7, Betty Yuen Kwan Law1,2.   

Abstract

Ischemia-reperfusion injury is a major reason for acute kidney injury and various kidney diseases. Autophagy plays an important role during renal ischemia-reperfusion injury (RIRI), but it remains controversial whether autophagy contributes to cell survival or ischemia-reperfusion-induced cell death. In the review, we summarized the function of autophagy in the progression of acute ischemic kidney injury, as well as its related molecular mechanisms. While analyzing the opposite roles of autophagy in RIRI, it was concluded that the protective or detrimental function of autophagy was depending on the timing and amount of the activation of cell autophagy. We also summarized the regulatory agents, including active compounds, proteins, or microRNAs (miRNAs), which regulated the cell autophagy during renal acute ischemic kidney injury process. This explained why the opposite conclusion occurred when cell autophagy was studied in the RIRI models from different researchers. Therefore, the article provided a hypothesis to control cell autophagy at the appropriate timing and intensity so as to alleviate renal injury and sustain cell survival of the renal cell.

Entities:  

Keywords:  IRI; autophagy; kidney; regulation

Mesh:

Substances:

Year:  2019        PMID: 31347925     DOI: 10.1089/dna.2019.4767

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  9 in total

1.  Ischemic Preconditioning Alleviates Mouse Renal Ischemia/Reperfusion Injury by Enhancing Autophagy Activity of Proximal Tubular Cells.

Authors:  Shun Zhang; Weimin Xia; Huangqi Duan; Xinyan Li; Subo Qian; Haibo Shen
Journal:  Kidney Dis (Basel)       Date:  2022-03-17

2.  miR-211-5p Alleviates the Myocardial Ischemia Injury Induced by Ischemic Reperfusion Treatment via Targeting FBXW7.

Authors:  Yonghui Liu; Jiatian Meng; Hongqin Di; Liheng Zheng; Zili Meng
Journal:  Biomed Res Int       Date:  2022-06-03       Impact factor: 3.246

3.  Ebselen ameliorates renal ischemia-reperfusion injury via enhancing autophagy in rats.

Authors:  Yikun Wu; Hua Shi; Yuangao Xu; Jun Pei; Shang Song; Wei Chen; Shuxiong Xu
Journal:  Mol Cell Biochem       Date:  2022-03-26       Impact factor: 3.396

Review 4.  A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer.

Authors:  Li Liu; Lu Yan; Ning Liao; Wan-Qin Wu; Jun-Ling Shi
Journal:  Cancers (Basel)       Date:  2020-02-04       Impact factor: 6.639

5.  TRPC6 ameliorates renal ischemic reperfusion injury by inducing Zn2+ influx and activating autophagy to resist necrosis.

Authors:  Youmin Pu; Hongwen Zhao; Bingbing Shen; Qiang Zhou; Pan Xie; Xiongfei Wu
Journal:  Ann Transl Med       Date:  2022-03

6.  Role of tRNA derived fragments in renal ischemia-reperfusion injury.

Authors:  Dan Li; Hao Zhang; Xueqin Wu; Qing Dai; Shiqi Tang; Yan Liu; Shikun Yang; Wei Zhang
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

7.  miRNA-182/Deptor/mTOR axis regulates autophagy to reduce intestinal ischaemia/reperfusion injury.

Authors:  Yunsheng Li; Yanhua Luo; Baochuan Li; Lijun Niu; Jiaxin Liu; Xiaoyun Duan
Journal:  J Cell Mol Med       Date:  2020-06-08       Impact factor: 5.310

8.  Inhibition of excessive mitophagy by N-acetyl-L-tryptophan confers hepatoprotection against Ischemia-Reperfusion injury in rats.

Authors:  Huiting Li; Yitong Pan; Hongjuan Wu; Shuna Yu; Jianxin Wang; Jie Zheng; Can Wang; Jianguo Li; Jiying Jiang
Journal:  PeerJ       Date:  2020-04-09       Impact factor: 2.984

9.  Eugenol Attenuates Cerebral Ischemia-Reperfusion Injury by Enhancing Autophagy via AMPK-mTOR-P70S6K Pathway.

Authors:  Xiaowei Sun; Dongyan Wang; Tingting Zhang; Xuejian Lu; Fangfang Duan; Lili Ju; Xiaotong Zhuang; Xicheng Jiang
Journal:  Front Pharmacol       Date:  2020-02-21       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.